VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1791562
Sex: M
Age:
State:

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Sore body all over; Fatigued; Just felt unwell; This is a spontaneous report from a non-contactable consumer, the patient. A 83-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Feb2021 at 16:00 (at the age of 83-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and diabetes. The patient was allergic to metropolis. Concomitant medications were not reported. The patient previously received niacin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Feb2021 at 06:00, the patient experienced sore body all over, fatigued, and just felt unwell. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore body all over, fatigued and just felt unwell was resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791563
Sex: F
Age:
State: CA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Chills; Exhaustion; Stiff neck; Abdominal cramps; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 27Feb2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer and allergy to opioids. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included anastrozole (MANUFACTURER UNKNOWN), valaciclovir (VALACYCLOVIR), vitamin d nos (MANUFACTURER UNKNOWN), vitamin b nos (MANUFACTURER UNKNOWN) and ascorbic acid, copper, zinc, xantofyl, zeaxanthin, vitamin e nos (AREDS 2). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Feb2021 at 14:30, the patient experienced chills, exhaustion, stiff neck, abdominal cramps, and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, exhaustion, stiff neck, abdominal cramps and diarrhea was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ANASTROZOLE; VALACYCLOVIR [VALACICLOVIR]; VITAMIN D NOS; VITAMIN B NOS; ASCORBIC ACID;COPPER;VITAMIN E NOS;XANTOFYL;ZEAXANTHIN;ZINC

Current Illness:

ID: 1791564
Sex: F
Age:
State: NJ

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 28Feb2021 at 09:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL FE 1.5/30) for an unknown indication from an unknown date and unknown if ongoing. On 28Feb2021 at 20:30, the patient experienced diarrhea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea and nausea were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL FE 1.5/30

Current Illness:

ID: 1791565
Sex: F
Age:
State: TN

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pain in the right arm at and around the injection site.; Extreme soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 27Feb2021 at 09:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) and multivitamin; both taken for an unknown indication on an unknown date and unknown if ongoing. On 27Feb2021 at 09:30, the patient experienced extreme soreness/ pain in the right arm at and around the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event extreme soreness/pain in the right arm at and around the injection site was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUPROPION

Current Illness:

ID: 1791566
Sex: M
Age:
State: NY

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Nausea on and off day after vaccine.; Fatigue; Chills; One episode of vomiting evening after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6202) via an unspecified route of administration in the left arm on 28Feb2021 at 09:45 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the vaccination. Concomitant medications included tetanus vaccine (MANUFACTURER UNKNOWN) taken on 08Feb2021 in the left arm for an unknown indication, amlodipine besilate (NORVASC), acetylsalicylic acid (ASA) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. On 28Feb2021, evening after vaccine, the patient experienced one episode of vomiting. On 01Mar2021 at 19:15, the patient experienced nausea on and off day after vaccine, fatigue and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea on and off day after vaccine, one episode of vomiting, fatigue and chills were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NORVASC; ASA

Current Illness:

ID: 1791567
Sex: M
Age:
State: NH

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Soreness in upper arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 01Mar2021 at 09:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient did not receive other medications within 2 weeks of vaccination. On 01Mar2021 at 10:00, the patient experienced soreness in upper arm. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791568
Sex: F
Age:
State: CT

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Sore arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Feb2021 at 11:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 23Feb2021, the patient experienced sore arm and headache. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and headache was recovered on an unknown date in Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791569
Sex: F
Age:
State: KY

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210227; Test Name: Body temperature; Result Unstructured Data: Test Result:95.6 Units:[degF]; Test Date: 20210227; Test Name: Body temperature; Result Unstructured Data: Test Result:95.4 Units:[degF]

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: About four hours after injection, I experienced lightheadedness and chills; I experienced lightheadedness and chills; I decided to check my temp, assuming I would be feverish. Instead, one thermometer read 95.4 F and the other thermometer read 95.6 F; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 27Feb2021 at 11:45 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, latex allergy and fruit allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN) and hydroxyzine (MANUFACTURER UNKNOWN) taken for an unknown indication in an unknown date and unknown if ongoing. The patient previously received hydrocodone (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Feb2021 at 17:00, about four hours after injection, the patient experienced lightheadedness and chills. The patient's husband (who did not receive the vaccine) noted that he felt warm, so the patient decided to check temperature, assuming would be feverish. Instead, one thermometer read 95.4 Degrees Fahrenheit and the other thermometer read 95.6 Degrees Fahrenheit. After wrapping up very warmly for a couple of hours, her temperature was normal again, but still experienced light headed for the rest of the day. On the same day, the patient underwent body temperature test and the result was 95.4 Degrees Fahrenheit and 95.6 Degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events lightheadedness, chills and feverish were recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; BUPROPION; BUSPIRONE; HYDROXYZINE

Current Illness:

ID: 1791570
Sex: M
Age:
State:

Vax Date: 02/20/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210222; Test Name: Work; Result Unstructured Data: Test Result:Unknown results; Comments: Nasal swab, Results pending.

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Headache; Dizziness; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 20-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Feb2021 at 13:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included dexmethylphenidate hydrochloride (FOCALIN) and escitalopram oxalate (LEXAPRO); both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Jan2021 at 13:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 22Feb2021 at 12:00, the patient experienced headache and dizziness after the second shot. Since the vaccination, the patient had been tested for COVID-19. On 22Feb2021, the patient underwent work COVID-19 test via nasal swab and the result was pending. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events headache and dizziness after the second shot was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: FOCALIN [DEXMETHYLPHENIDATE HYDROCHLORIDE]; LEXAPRO.

Current Illness:

ID: 1791571
Sex: F
Age:
State: NY

Vax Date: 02/21/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Feb2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multi-vitamins (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Feb2021, the patient experienced sore arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was resolved on an unknown date in Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791572
Sex: M
Age:
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210126; Test Name: AE severity; Result Unstructured Data: Test Result:6-7 out of 10

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Abdominal pain; This is a spontaneous report from a non-contactable physician. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on 26Jan2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on an unspecified date for covid-19 immunization, flu vaccine and shingles vaccine. On 26Jan2021, the patient experienced abdominal pain. AE severity was "6-7 out of 10". The outcome of the event was recovered on 28Jan2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791573
Sex: M
Age:
State: NY

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Severe headache; moderate fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Feb2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 16:00, the patient experienced severe headache and moderate fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache and moderate fatigue was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791574
Sex: F
Age:
State: AZ

Vax Date: 01/10/2021
Onset Date: 01/17/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Increased nasal congestion; mucous production; nasal mucous requiring frequent and productive nose blowing; It is an almost constant irritant; This is a spontaneous report from a contactable nurse, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1283) via an unspecified route of administration in the left arm on 10Jan2021 at 12:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS), gastroesophageal reflux disease (GERD) and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received an unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the left arm on 12Dec2020 at 00:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. On 17Jan2021 at 12:00, the patient experienced increased nasal congestion and mucous production which had continued for more than six weeks, with no other symptoms, no illness with just excessive nasal mucous requiring frequent and productive nose blowing and was almost constant irritant. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events increased nasal congestion, mucous production, nasal mucous requiring frequent and productive nose blowing, constant irritant were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791575
Sex: F
Age:
State: VA

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Swollen lymph nodes 4 days after 2nd dose; Administration date 21Feb2021, dose number=2/ administration date 03Feb2021, dose number=1; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 21Feb2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. It was unknown if the patient had any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 25Feb2021 at 12:00, the patient experienced swollen lymph nodes, 4 days after the second dose. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of event reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791576
Sex: M
Age:
State: NJ

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: stomach cramps; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 20Feb2021 at 17:00 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, irritable bowel syndrome and benign prostatic hyperplasia. The patient previously took barium (MANUFACTURER UNKNOWN) and esomeprazole sodium (NEXIUM) for an unknown indication from an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ), doxazosin mesilate (CARDURA), amitriptyline hydrochloride (AMITRIPTYLENE) and finasteride (FINASTERID); all taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the right arm on 29Jan2021 as a single dose for COVID-19 immunisation and experienced diarrhea and stomach cramps. On 20Feb2021 at 11:00 the patient experienced stomach cramps and diarrhea. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stomach cramps and diarrhea was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PANTOPRAZOLE; HYDROCHLOROTHIAZIDE; CARDURA; AMITRIPTYLENE; FINASTERID

Current Illness:

ID: 1791577
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Dizziness that turned into vertigo andvomiting; Dizziness; Dizziness that turned into vertigo; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 25Feb2021 at 16:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included eosinophilia myalgia syndrome. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all for an unknown indication on an unknown dates and unknown if ongoing. On 26Feb2021, the patient experienced dizziness that turned into vertigo and vomiting. She also reported that the two episodes lasted about 20 minutes each. The vertigo was so bad that she could not see or function. If she had been driving she could have crashed. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting, dizziness and vertigo were resolved on an unknown date in Feb2021 after the duration of 20 minutes. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: AMITRIPTYLINE; GABAPENTIN; PROZAC

Current Illness:

ID: 1791578
Sex: U
Age:
State: MI

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: pain level; Result Unstructured Data: Test Result:2; Comments: out of 10

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: a sore deltoid at and surrounding the injection point (pain level 2 out of 10); This is a spontaneous report received from a contactable consumer (patient) in response to the mail trail sent regarding the confirmation of below mentioned query sent in cross referenced case. The response included that: A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection) via an unspecified route of administration on 19Feb2021 11:30 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection) via an unspecified route of administration, on 28Jan2021 at 08:15 as dose 1, single for covid-19 immunization and experienced sore leg at approx. 18:00 that evening (pain level 3 out of 10 similar to growing pains, more of a nuisance). On 19Feb2021, the patient experienced a sore deltoid at and surrounding the injection point (pain level 2 out of 10) which lasted approx. 24 hrs. Upon follow up 08Mar2021 response include when patient was aware of second dose AE "a sore deltoid at and surrounding the injection point". When it happened and is it on 19Feb2021. First dose AE "sore leg" awareness date was 28Jan2021, but patient reported on 11Feb2021 which is delay and second dose's AE ""a sore deltoid at and surrounding the injection point", if the onset date was 19Feb2021, but patient reported it on 23Feb2021, which will also mean delay. Patients need to report within 24 hours please help for delay comment. Patient stated, I received the 2nd COVID-19 vaccine on 19Feb2021 at 11:30 and I only experienced a sore deltoid at and surrounding the injection point (pain level 2 out of 10), which lasted approx. 24 hrs. and to be clear my deltoid was sore on 19Feb2021 and was not sore the next day. I no longer have a sore deltoid. The patient underwent lab tests and procedures which included pain assessment: 2 out of 10 on 19Feb2021. The outcome of the event was recovered on 20Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1791579
Sex: F
Age:
State: MN

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Chills; Injection site pain; light headed approximately 6 hours after the shot was administered; inappropriate schedule of drug administered; This is a spontaneous report from a non-contactable consumer, the patient. An 89-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the right arm on an unknown date in Feb2021 (at the age of 89-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the right arm on an unknown date in Feb2021 as a single dose for COVID-19 immunisation. On 18Feb2021, the patient experienced chills, injection site pain and light headed approximately 6 hours after the shot was administered. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, injection site pain and light headed was resolved on an unknown date in Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791580
Sex: F
Age:
State:

Vax Date: 02/22/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Feeling lightheaded; Lethargic; Arm weakness; Sluggish when answering questions; This is a spontaneous report from a non-contactable healthcare professional. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration on 22Feb2021 at 09:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient previously received influenza vaccine (MANUFACTURER UNKNOWN) (reported as H1N1 vaccine) for an unknown indication on an unknown date and experienced allergy to vaccine. On an unknown date in Feb2021, following the injection, the patient reported feeling lightheaded, lethargic, arm weakness, and she was sluggish when answering questions. The events resulted in emergency room/department or urgent care. The clinical outcome of the events feeling lightheaded, lethargic, arm weakness and sluggish when answering questions was unknown at the time of this report. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791581
Sex: F
Age:
State: WY

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Right arm soreness; Diarrhea; Hot flash; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the right arm on 24Feb2021 at 11:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included arterial spasm. The patient previously received collagen (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lysine (MANUFACTURER UNKNOWN), diltiazem hydrochloride (CARTIA XT), calcium (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and acetylsalicylic acid (ASPIRIN); all medications from an unknown date, unknown if ongoing and for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Feb2021 at 10:30, the patient experienced right arm soreness, diarrhea and hot flash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm soreness, diarrhea and hot flash were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LYSINE; CARTIA XT; CALCIUM; VITAMIN D3; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1791582
Sex: F
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: eye pain; headache; Pressure in the eyes; This is a spontaneous report from a contactable consumer (patient). A 30-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3247 and expiry date was not reported), via an unspecified route of administration, in left arm on 19Feb2021 at 12:15 PM (age at vaccination: 30-Year-old), as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included ibuprofen (ADVIL), taken for an unspecified indication, start and stop date were not reported. The patient did not receive any vaccine within four weeks prior to covid-19 vaccine. The patient was not diagnosed with covid-19 prior vaccination and not tested for covid-19 post vaccination. The patient was not allergic to any of the medications. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3247 and expiry date was not reported), via an unspecified route of administration, in left arm on 29Jan2021 at 12:15 PM (age at vaccination: 30-Year-old), as DOSE 1, SINGLE for COVID-19 immunisation and experienced headache. On 20Feb2021 at 13:00, the patient experienced headache, pressure in the eyes and eyes felt sore. It started with a headache that reached the eye area after about 24 hrs of taking the vaccine. The headache was present after the first dose, but without the eye pain. Events persisted for 2.5 days. The patient did not receive any treatment for the events. Outcome of the events was recovered on an unspecified date in Feb2021.

Other Meds: ADVIL [IBUPROFEN]

Current Illness:

ID: 1791583
Sex: F
Age:
State:

Vax Date: 02/06/2021
Onset Date: 02/23/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202102; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:unknown results; Comments: Since the vaccination, has the patient been tested for COVID-19?:Yes

Allergies:

Symptom List: Unevaluable event

Symptoms: Muscle pain; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Feb2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (prior to the vaccination, the patient was diagnosed with COVID-19). The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT) taken for an unknown indication from an unknown date and unknown if ongoing. On 23Feb2021, the patient experienced muscle pain in lower right arm from elbow on down which started 2.5 weeks after the vaccination. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. On an unknown date in Feb2021, the patient underwent COVID-19 virus test and the result was unknown. The clinical outcome of the event muscle pain was not recovered at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1791584
Sex: M
Age:
State: NJ

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: injection site soreness in my left arm.; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 24Feb2021 at 13:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, hypertension, pet dander allergy, dust allergy, eggs allergy, pollen allergy and apples allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID -19 vaccine. Concomitant medications included metformin (MANUFACTURER UNKNOWN), olmesartan (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and metoprolol (MANUFACTURER UNKNOWN); all for unknown indication from an unknown dates and unknown if ongoing. It was reported that the patient was a Pfizer colleague and had received the first dose of the vaccine at the Pfizer clinic. On 24Feb2021, the patient experienced injection site soreness in his left arm. It was mild on the previous day more intense on the day of report. The patient did not experienced any further adverse events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of the adverse event which included the treatment with TYLENOL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event injection site soreness in left arm was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN; OLMESARTAN; VITAMIN D3; METOPROLOL

Current Illness:

ID: 1791585
Sex: F
Age:
State:

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 19Feb2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 20Feb2021, the patient experienced headache. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was resolved on an unknown date in Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791586
Sex: F
Age:
State:

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Soreness at injection site; This is a spontaneous report from a non-contactable pharmacist, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 22Feb2021 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to melons. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin hydrochloride (METFORMIN ER) for an unknown indication from an unknown date and unknown if it was ongoing. On 22Feb2021, the patient experienced soreness at injection site. Therapeutic measures were not taken as a result of the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness at injection site was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN ER

Current Illness:

ID: 1791587
Sex: F
Age:
State: WV

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: soreness at the injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number reported as EN5318; Expiration Date reported as May2021) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number reported as EL3248, Expiration Date was not reported). The patient's medical history and concomitant medications were not reported. The reporter stated that, she experienced some dehydration the following day after her first dose. She called to see if that was a side effect. The next day she was fine. The only side effect she experienced was minimal soreness at the injection site after both doses on an unspecified date. If she had serious side effect, she would have completed the questionnaire. The outcome for the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1791588
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fatigue; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unspecified date as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications were not reported. The patient had no known allergies to food, medications and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date, the patient experienced fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue and headache was recovered on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791589
Sex: F
Age:
State: PA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Slept poorly that night and felt like heart rate may have been slightly elevated.; Anxiety; soreness in arm greater than normal flu shot, but it is subsiding; Slept poorly that night; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the right arm on 24Feb2021 at 09:00 (at the age of 61-year-old), as a single dose for COVID-19 immunisation. Medical history included heart diease, raynauds and allergy to pre-surgical wipes which caused significant rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetylsalicylic acid (ASPIRIN), amlodipine (MANUFACTURER UNKNOWN) and simvastatin (MANUFACTURER UNKNOWN) taken for unspecified indications, from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 24Feb2021 at 22:00, the patient slept poorly that night and felt like heart rate may had been slightly elevated. The patient was not a great sleeper and had heart disease so considered it possibly related to anxiety. On same day, patient experienced soreness in arm greater than normal when had flu shot, but it was subsiding. The patient was feeling better currently and heart rate seemed normal. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events slept poorly that night and felt like heart rate may have been slightly elevated, possibly related to anxiety and soreness in arm greater than normal was recovered on an unknown date in Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; AMLODIPINE; SIMVASTATIN

Current Illness:

ID: 1791590
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Headache; Nausea; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 24Feb2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included rosuvastatin calcium (CRESTOR), ascorbic acid (VITAMIN C) and vitamin d nos (VITAMIN D), all for an unknown indication from an unknown dates and unknown if ongoing. On 25Feb2021, the patient experienced headache, nausea and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea and fatigue was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: CRESTOR; VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1791591
Sex: M
Age:
State: CT

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: slight headache; sore muscles; tired feeling all day; felt like a bee sting; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on the right arm on 24Feb2021 at 09:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multivitamins, not every day of the week. The patient previously received first dose of BNT162b2 (COMIRNATY, Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 24Feb2021 at 09:30, second shot when administered the patient felt like a bee sting for about 5 minutes and sore arm. Next morning, on 25Feb2021 the patient experienced slight headache, sore muscles and tired feeling all day. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt like a bee sting, sore arm, slight headache, sore muscles and tired feeling all day were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791592
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: dizziness; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (father) reported that a male patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 on an unspecified date for covid-19 immunisation. The patient experienced dizziness 5 days after the second shot on an unspecified date. The outcome of the event was unknown. No follow-up attempts are needed; information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791593
Sex: F
Age:
State: NM

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 25Feb2021 at 10:00 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included migraine, obesity, asthma and allergy to antibiotic. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), erenumab (AIMOVIG), naproxen sodium (ALEVE), rizatriptan benzoate (MAXALT) and melatonin (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 25Feb2021 at 11:00, the patient experienced metallic taste in mouth. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event metallic taste in mouth was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; AIMOVIG; ALEVE; MAXALT; MELATONIN

Current Illness:

ID: 1791594
Sex: F
Age:
State: MN

Vax Date: 02/04/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Arm sore; This is a spontaneous report from a contactable healthcare professional, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL926) via an intramuscular route of administration in the arm left on 04Feb2021 at 16:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 04Feb2021, after first dose of vaccination the patient had got arm sore for 4 or 5 days for her 1st dose. It was reported that it was helpful but different than other vaccination(details unspecified). It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm sore was resolved on an unknown date in Feb2021. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an intramuscular route of administration in the arm left on 25Feb2021 at 15:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791595
Sex: M
Age:
State: IL

Vax Date: 02/17/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: "I" have swollen lymph nodes.; What should I do to help with pain; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 17Feb2021(at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 29Jan2021(at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 01Mar2021, the patient had swollen lymph nodes and lymph node pain. The patient did not know when his swollen lymph nodes would return to normal and what would help his pain. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes and lymph node pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791596
Sex: F
Age:
State: CA

Vax Date: 02/24/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Tender lymph nodes in armpit; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 24Feb2021 at 14:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history includes allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fish oil (MANUFACTURER UNKNOWN); progesterone (MANUFACTURER UNKNOWN), withania somnifera (ASHWAGANDHA) and multivitamins (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. On 27Feb2021, the patient experienced tender lymph nodes in armpit. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tender lymph nodes in armpit was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ASHWAGANDHA; PROGESTERON; FISH OIL

Current Illness:

ID: 1791597
Sex: F
Age:
State: MA

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Swollen glands under right arm (same arm as vaccinated); This is a spontaneous report from a contactable other healthcare professional, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11Feb2021 at 12:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as not applicable. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Jan2021 at 12:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced swollen glands under right arm (same arm as vaccinated). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen glands under right arm was recovered on unknown date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: GABAPENTIN

Current Illness:

ID: 1791598
Sex: M
Age:
State: VA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: About 18 hours after receiving the second dose of the vaccine, started to experience severe body aches from my neck to my knees. The body aches continued until about 48 hours after vaccination.; Redness at the injection site in left arm; Developed a swollen lymph node lump at the base of left armpit.; About 24 hours after receiving the second dose of the vaccine, began to experience chills. Was unable to control the body temperature even by taking hot showers and wearing multiple layers of clothing underneath blankets in bed.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 27Feb2021 at 13:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa-based medications (sulfonamide allergy) and penicillin-based medications (penicillin allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 06Feb2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 28Feb2021 at 07:30, about 18 hours after receiving the second dose of the vaccine, the patient started to experience severe body aches from neck to knees. The body aches continued until about 48 hours after vaccination. On 28Feb2021, about 24 hours after receiving the second dose of the vaccine, the patient began to experience chills. The worst of the chills came at about 30 hours posts vaccination. The patient was unable to control body temperature even by taking hot showers and wearing multiple layers of clothing underneath blankets in bed. Throughout this time on 28Feb2021 at 07:30, the patient also experienced redness at the injection site in left arm, and developed a swollen lymph node lump at the base of left armpit. That swelling still had not dissipated after 72 hours since vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe body aches from neck to knees was resolved on 01Mar2021 48 hours after vaccination; while that of the events chills, redness at the injection site in left arm and swollen lymph node lump at the base of left armpit was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791599
Sex: M
Age:
State: MD

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Injection site soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9269) via an unspecified route of administration in the left arm on 01Mar2021 at 15:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion hydrobromide (APLENZIN) and sertraline (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 02Mar2021 at 00:00, the patient experienced injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event injection site soreness was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: APLENZIN; SERTRALINE

Current Illness:

ID: 1791600
Sex: F
Age:
State: IL

Vax Date: 02/24/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Severely swollen supraclavicular & axillary lymph nodes on the left side; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Feb2021 at 17:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 27Feb2021, the patient experienced severely swollen supraclavicular and axillary lymph nodes on the left side. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severely swollen supraclavicular and axillary lymph nodes on the left side was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791601
Sex: M
Age:
State: CA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Strange bitter taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 02Mar2021 at 11:45 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history reported as not applicable. The patient did not have known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Mar2021, after about 15 minutes (also reported as 11:45), the patient experienced strange bitter taste in mouth and somewhat metallic in nature. It had been another 15 or so minutes and still it was there. The patient did not eat or drink anything hours before and he had still did not drink anything. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event strange bitter taste in mouth was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791602
Sex: F
Age:
State: NV

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Painful urination and bladder spasms; Painful urination and bladder spasms; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, pre-diabetic, kidney stones, diverticulosis and obesity. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), fexofenadine (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN); all taken for an unspecified indication, from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 09Jan2021 at 00:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient previously received erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 02Mar2021, at 00:00, the patient experienced painful urination and bladder spasms. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful urination and bladder spasms was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Allopurinol; Pantoprazole; Fexofenadine; Erythromycin

Current Illness:

ID: 1791603
Sex: M
Age:
State: NJ

Vax Date: 02/08/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210224; Test Name: Blood test; Result Unstructured Data: Test Result:Eosinophil value as 0

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Routine blood draw on 24Feb2021 showed Eosinophil value as 0; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 08Feb2021 at 18:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, high cholesterol and atrial fibrillation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. On 24Feb2021, the patient experienced routine blood draw that showed eosinophil value as 0. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. On 24Feb2021, the patient underwent blood test and the result was found to be eosinophil value as 0. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event routine blood draw showed Eosinophil value as 0 was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791604
Sex: F
Age:
State: NJ

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210223; Test Name: SARS COVID 2 Panther; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210212; Test Name: SARS COVID 2 Panther; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210207; Test Name: SARS COVID 2 Panther; Test Result: Negative ; Comments: Nasal swab; Test Date: 20210223; Test Name: SARS-CoV-2 Rapid ag (COVID-19); Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210212; Test Name: SARS-CoV-2 Rapid ag (COVID-19); Test Result: Negative ; Comments: Nasal Swab; Test Date: 20210207; Test Name: SARS-CoV-2 Rapid ag (COVID-19); Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: About an hour after receiving the first vaccination on 1/15/2021, she experienced pain in arm.; Body aches; Fatigue; Nausea; Headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Jan2021 at 12:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included bunionectomy, eczema, ichthiosis vulgaris(mild), wear contacts and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included hydroxyzine (MANUFACTURER UNKNOWN), dexamfetamine (D-AMPHETAMINE) and linaclotide (LINZESS); all for an unknown indication from an unknown date and unknown if ongoing. On 15Jan2021, about an hour after receiving the first vaccination the patient experienced pain in arm, body aches, fatigue, nausea, and headache. The patient realized that these were common side effects and just monitored the symptoms. They started to go away the next day on 16Jan2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 07Feb2021, the patient underwent SAR-COV-2 Test (Rapid AG) via nasal swab and the result was Negative. On 07Feb2021, the patient underwent SAR-COV-2 Test (Panther) via nasal swab and the result was Negative. On 12Feb2021, the patient underwent SAR-COV-2 Test (Rapid AG) via nasal swab and the result was Negative. On 12Feb2021, the patient underwent SAR-COV-2 Test (Panther) via nasal swab and the result was Negative. On 23Feb2021, the patient underwent SAR-COV-2 Test (Rapid AG) via nasal swab and the result was Negative. On 23Feb2021, the patient underwent SAR-COV-2 Test (Panther) via nasal swab and the result was Negative. The clinical outcome of the events pain in arm, body aches, fatigue, nausea, and headache were resolved on 16Jan2021. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Feb2021(at the age of 28-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: HYDROXYZINE; DEXTROAMPHETAMINE [DEXAMFETAMINE]; LINZESS

Current Illness:

ID: 1791605
Sex: F
Age:
State: CT

Vax Date: 02/12/2021
Onset Date: 02/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210215; Test Name: Nasal swab; Test Result: Negative.

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Booster dose administered; Off- label use; A few days after dose 2 had sore arm; Shortly after that I developed pink eye; This is a spontaneous report from a contactable consumer, the patient. A 87-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Feb2021 at 11:00 (at the age of 87-years-old) and a third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Feb2021 (at the age of 87-years-old) as a single dose for COVID-19 immunisation. Medical history included two coronary stents, left anterior descending artery (LAD), two knees and allergic to penicillin. Concomitant medications included Statins and olmesartan (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 15Feb2021, a few days after dose number two the patient had sore arm. Shortly after that developed pink eye. Therapeutic measures were taken as a result of pink eye and included treatment with antibiotic eye drops. Since the vaccination, the patient had been tested for COVID-19. On 15Feb2021, the patient underwent COVID-19 test via nasal swab and the result found to be negative. The clinical outcome of the events a few days after dose number two the patient had sore arm; shortly after that developed pink eye was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: OLMESARTAN.

Current Illness:

ID: 1791606
Sex: M
Age:
State: NY

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Sore arm near area of injection; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 02Mar2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 19:00, the patient experienced sore arm near area of injection. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm near area of injection was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791607
Sex: F
Age:
State: NY

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210217; Test Name: MRI; Result Unstructured Data: Test Result:Negative; Test Date: 20210217; Test Name: CT scan; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Slurred speech; Aphasia; Irregular migraine provoked by vaccine; The evening of 16Feb2021, felt slightly dizzy with a moderate headache.; The evening of 16Feb2021, felt slightly dizzy with a moderate headache.; This is a spontaneous report from a contactable nurse, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3246) via an unspecified route of administration in the left arm on 16Feb2021 at 16:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety, ruptured uterus with exsanguination, hypertension, COVID-19 and known allergy to sulfa. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient previously also received prednisone (MANUFACTURER UNKNOWN), celecoxib (CELEBREX) and gabapentin (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN) and topiramate (TOPAMAX); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 27Jan2021 at 12:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 16Feb2021 at 20:30, the evening of the day of vaccination, the patient felt slightly dizzy with a moderate headache. On 17Feb2021 at 06:30, after the patient woke up, the patient experienced slurred speech with aphasia, the patient was unable to speak clearly and the words that did come out were not the correct words. The patient was trying to convey and was taken to ER at that time. Diagnosis was an irregular migraine provoked by vaccine. On 17Feb2021, the patient underwent computerized tomography and magnetic resonance imaging scan and the results were negative. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the event which included emergency room visit, computerized tomography and magnetic resonance imaging scan and neurology appointment. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt slightly dizzy with a moderate headache, irregular migraine provoked by vaccine, slurred speech and aphasia was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUPROPION; VENLAFAXINE; TOPAMAX

Current Illness:

ID: 1791608
Sex: F
Age:
State: CA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: "I" have Rheumatoid Arthritis. It's been3 days since "my" vaccine and all of "my" RA symptoms are gone!!! "I" haven't felt this good for about a year!! "My" inflammation is completely nonexistent right now!; "I" have Rheumatoid Arthritis. It's been3 days since "my" vaccine and all of "my" RA symptoms are gone!!! "I" haven't felt this good for about a year!! "My" inflammation is completely nonexistent right now!; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG198) via an unspecified route of administration in the left arm on 27Feb2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, degenerative disc disease and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified medication within two weeks of vaccination. On 28Feb2021, It was reported that the patient had rheumatoid arthritis. It had been 3 days since her vaccine and all of her rheumatoid arthritis symptoms were gone (pre-existing condition improved and unexpected therapeutic benefit). The patient had not felt this good for about a year. Her inflammation was completely non-existent at the time of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events patient had rheumatoid arthritis. It had been 3 days since her vaccine and all of her rheumatoid arthritis symptoms were gone (pre-existing condition improved and unexpected therapeutic benefit). The patient hadn't felt this good for about an year. Her inflammation was completely non-existent right now was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791609
Sex: F
Age:
State: NY

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Lesser effects day 2 but lymph nodesall over started hurting; Sore behind ears and pain worse on left side; pain at injection arm and armpit; pain at injection arm and armpit; Bad insomnia since then, waking up unable to go back to sleep, normally don't have insomnia.; Extremely heavy feeling in my head then whole body; Extremely heavy feeling in my head then whole body; woozy felt; disoriented or drunk; Weakness, having trouble standing withoutleaning on something.; Slight chills; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198,) via an unspecified route of administration in the left arm on 28Feb2021 at 12:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergic rhinitis, conjunctivitis, attention deficit hyperactivity disorder (ADHD), depression, anxiety, pollen allergy (tree pollens), allergy to molds, strong seasonal allergies and had loop electrosurgical excision procedure (LEEP) procedure 10 days before the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), atomoxetine (MANUFACTURER UNKNOWN), and many more unspecified medications; all from an unknown date and unknown if ongoing for an unknown indication. The patient previously received cefaclor (CECLOR) and experienced allergy. On 28Feb2021 at 15:45, the patient had an extremely heavy feeling in the head and then to the whole body and also felt woozy, disoriented or drunk, weakness due to which trouble standing without leaning on something and slight chills and all these effects occurred very fastly. On 01Mar2021, day 2, the patient had lesser effects however the patient experienced lymph nodes all over hurting, sore behind ears and pain worse on the left side, pain at injection arm and armpit. On the same day, the patient also experienced bad insomnia since vaccination due to which the patient woke up but was unable to go back to sleep and was reported that normally the patient did not have insomnia. The events resulted in doctor or other healthcare professional office/clinic visits. Therapeutic measures were taken as a result of the events included the psychiatrist's suggestion to off bupropion medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely heavy feeling in the head then to the whole body, felt woozy, disoriented or drunk, weakness trouble standing without leaning on something, slight chills, lymph nodes all over hurting, especially sore behind ears/ pain worse on the left side, pain at injection arm and armpit and bad insomnia were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUPROPION; ATOMOXETINE

Current Illness:

ID: 1791610
Sex: M
Age:
State: PA

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Mild body aches; Mild upset stomach; Mild fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 01Mar2021 at 14:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ibuprofen (ADVIL) for unspecified indications, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the right arm on 08Feb2021 at 13:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 02Mar2021 at 13:00, the patient experienced mild body aches, mild upset stomach and mild fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild body aches, mild upset stomach and mild fatigue was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVIL [IBUPROFEN]

Current Illness:

ID: 1791611
Sex: F
Age:
State: IA

Vax Date: 02/13/2021
Onset Date: 02/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: migraine; sick; awful smell and taste; awful smell and taste; This is a spontaneous report from a contactable other healthcare professional, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Feb2021 at 15:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included adhd (attention deficit hyperactivity disorder), depression and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine/saccharate/dexamfetamine sulfate (ADDERALL), bupropion hydrochloride (WELLBUTRIN) and vitamin d nos (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Jan2021 at 13:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The previously received ciprofloxacin (CIPRO) on unknown date for unknown indication and experienced drug allergy. On 18Feb2021 at 12:00, after second shot, the patient had experienced migraine about a week later and got sick and since the patient had an awful smell and taste that was present often, when the patient had COVID-19 she experienced smell and taste was affected it took about a month or so to get her taste back somewhat and smell had never been the same. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, sick, awful smell and taste was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL; WELLBUTRIN; VITAMIN D NOS

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am